Advertisement
Advertisement
KYTX
Kyverna Therapeutics, Inc. Common Stock
7.07
USDSponsored
-0.44
-5.86%
Sep 23, 15:59 UTC -4
Closed
After-Market
7.29
+0.22
+3.11%
Kyverna Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 450.84M |
| Beta | 1.98 |
| Earnings Per Share (EPS) | -2.94 |
| Price-to-Book (P/B) Ratio | 2.61 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 15.11% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -81.92% |
| Current Ratio | 9.06% |
| Free Cash Flow | -82.20M |
